Status:
COMPLETED
Predicting 28-Day Mortality in Subarachnoid Hemorrhage
Lead Sponsor:
Haseki Training and Research Hospital
Conditions:
Subarachnoid Hemorrhage, Aneurysmal
Eligibility:
All Genders
18+ years
Brief Summary
The investigators investigated the predictive ability of clinical and radiological scores, including the Glasgow coma scale (GCS), Hunt-Hess, World Federation of Neurological Surgeons (WFNS), and modi...
Detailed Description
Patients were divided into survivors and non-survivors, with surviving patients further categorized as either mobile or immobile based on the Glasgow outcome scale. Accordingly, patients who were depe...
Eligibility Criteria
Inclusion
- patients (aged ≥ 18 years) who presented to the emergency department with non-traumatic Subarachnoid Hemorrhage between September 2020 and September 2023
Exclusion
- patients younger than 18 years
- patients with missing information
- patients with traumatic SAH
- patients with subdural or epidural hemorrhage
- patients with concurrent ischemic stroke
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
451 Patients enrolled
Trial Details
Trial ID
NCT06563219
Start Date
September 1 2020
End Date
August 1 2024
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haseki Training and Research Hospital
Istanbul, Fatih, Turkey (Türkiye), 34265